Sign inJoin waitlistJoin the waitlist

Douglas Graham

Pediatrics / Pediatric Hematology-Oncology

Credentials: · · · ·

History

Pediatrics

Research

TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer
Review · Advances in cancer research · 2008 · Last of 4 authors · 622 citations
The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer
Review · Nature reviews. Cancer · 2014 · First of 4 authors · 615 citations
A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation
Blood · 2007 · Last of 7 authors · 280 citations

HE
Henry Earp
44 papers
Xiayuan Liang
16 papers
Amy Keating
14 papers
AS
Alisa Lee Sherick
11 papers · 1 as a resident
Christopher Cummings
10 papers · 1 as a resident
KM
Katherine Minson
8 papers
Brian Branchford
6 papers · 2 as a fellow
Daniel Wechsler
6 papers · 2 as a fellow
Madeline Higgins
6 papers
Sunil Raikar
6 papers
EV
Eleana Vasileiadi
5 papers · 2 as a resident
Greg Kirkpatrick
5 papers

Grants

Discovery of a Novel MDM2-Tubulin Signaling Pathway as a Therapeutic Target in AML
National Cancer Institute · R01
PI · $1.6M · Emory University
2023–2028
Novel TYRO3 Inhibitors for Treatment of Cancer
National Cancer Institute · R01
PI · $1.6M · Univ of North Carolina Chapel Hill
2021–2027
MERTK/AXL Dual Inhibitors Provide Novel Treatment for Cancer by Targeting Tumor Cells and Activating Anti-Tumor Immunity
National Cancer Institute · R01
PI · $2.5M · Univ of North Carolina Chapel Hill
2020–2026
Administrative Supplement: Interim Funding for Emory Lung Cancer SPORE
National Cancer Institute · P50
Project lead · $1.9M · Emory University
2019–2025